We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVTY
1901
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $5.84M | ﹤0.01% |
287,000
-2,788
| -1% | -$52.2K |
|
1902
CytomX Therapeutics
CTMX
$754M
| $5.84M | ﹤0.01% |
702,308
-41,278
| -6% | -$279K |
|
1903
Goldgroup Mining Inc.
GORO
$191M
| $5.82M | ﹤0.01% |
1,050,145
-22,322
| -2% | -$97.4K |
|
|
VBTX
1904
DELISTED
Veritex Holdings
VBTX
| $5.79M | ﹤0.01% |
198,831
-6,899
| -3% | -$177K |
|
|
EXTN
1905
DELISTED
Exterran Corporation
EXTN
| $5.79M | ﹤0.01% |
739,478
-43,418
| -6% | -$403K |
|
1906
Voyager Therapeutics
VYGR
$201M
| $5.79M | ﹤0.01% |
414,973
-107,086
| -21% | -$1.56M |
|
1907
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $5.79M | ﹤0.01% |
189,297
+689
| +0.4% | +$19.6K |
|
1908
Photronics
PLAB
$1.93B
| $5.78M | ﹤0.01% |
366,499
-165,668
| -31% | -$2.08M |
|
1909
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $5.75M | ﹤0.01% |
17,854
+6,094
| +52% | +$1.88M |
|
1910
S&T Bancorp
STBA
$1.79B
| $5.72M | ﹤0.01% |
142,083
+7,401
| +5% | +$280K |
|
1911
Cal-Maine
CALM
$3.99B
| $5.69M | ﹤0.01% |
133,175
-3,554
| -3% | -$148K |
|
1912
TotalEnergies
TTE
$190B
| $5.68M | ﹤0.01% |
102,746
+130
| +0.1% | +$6.87K |
|
|
ADAM
1913
Adamas Trust
ADAM
$883M
| $5.67M | ﹤0.01% |
227,702
+13,506
| +6% | +$335K |
|
1914
Dave & Buster's
PLAY
$357M
| $5.67M | ﹤0.01% |
141,227
-15,355
| -10% | -$615K |
|
1915
Alamo Group
ALG
$2.05B
| $5.66M | ﹤0.01% |
45,104
+668
| +2% | +$78.1K |
|
1916
Marcus Corp
MCS
$945M
| $5.66M | ﹤0.01% |
178,237
-3,465
| -2% | -$117K |
|
1917
Regenxbio
RGNX
$708M
| $5.66M | ﹤0.01% |
138,190
-42,929
| -24% | -$1.7M |
|
|
BRSL
1918
Brightstar Lottery PLC
BRSL
$2.03B
| $5.66M | ﹤0.01% |
377,836
-70,856
| -16% | -$1.01M |
|
1919
Cars.com
CARS
$660M
| $5.65M | ﹤0.01% |
462,601
-1,005,430
| -68% | -$11.7M |
|
1920
Coca-Cola Consolidated
COKE
$12.8B
| $5.64M | ﹤0.01% |
198,720
-238,400
| -55% | -$6.67M |
|
1921
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $5.63M | ﹤0.01% |
93,917
+31,100
| +50% | +$1.7M |
|
|
CONN
1922
DELISTED
Conn's Inc.
CONN
| $5.62M | ﹤0.01% |
453,235
+370,813
| +450% | +$7.77M |
|
1923
Hackett Group
HCKT
$287M
| $5.61M | ﹤0.01% |
347,786
-94,312
| -21% | -$1.5M |
|
|
FARO
1924
DELISTED
Faro Technologies
FARO
| $5.61M | ﹤0.01% |
111,355
-1,510
| -1% | -$73.8K |
|
1925
Harmonic Inc
HLIT
$1.28B
| $5.6M | ﹤0.01% |
718,470
-7,733
| -1% | -$57.7K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.